10
Participants
Start Date
December 15, 2024
Primary Completion Date
June 14, 2026
Study Completion Date
December 14, 2026
iNK cells
Intravenous infusion of iNK cells is given to the subject, 5\*108 to 1\*109 cells/dose, three doses per week, a total of 6 doses. And then 1\*109 cells/dose, one doses every 4 weeks , a total of 5 doses.
Weifang People's Hospital, Weifang
Weifang People's Hospital
OTHER
Guangzhou Ruixin Biotechnological Co., LTD
INDUSTRY